z-logo
open-access-imgOpen Access
An Overview of Pharmaceutical Cocrystals as Intellectual Property
Author(s) -
A.V. Trask
Publication year - 2007
Publication title -
molecular pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 127
eISSN - 1543-8392
pISSN - 1543-8384
DOI - 10.1021/mp070001z
Subject(s) - cocrystal , intellectual property , pharmaceutical sciences , business , engineering ethics , nanotechnology , law and economics , political science , law , medicine , chemistry , engineering , pharmacology , materials science , sociology , organic chemistry , hydrogen bond , molecule
This review article focuses on the interaction among certain scientific, legal, and regulatory aspects of pharmaceutical crystal forms. The article offers an analysis of pharmaceutical cocrystals as patentable inventions by drawing upon recent scientific developments in the field. Several potential commercial advantages of pharmaceutical cocrystals are highlighted, and a number of recent court decisions involving salient issues are summarized. The article provides an outlook on how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom